AbbVie Inc. (US)

Alle Meldungen

26.07

AbbVie Inc. (US) AbbVie Inc. (US)

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis

Immunology R&D News July 26, 2024 AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis Open a printable version of this page Email the URL of...

Zur Pressemeldung auf news.abbvie.com
25.07

AbbVie Inc. (US) AbbVie Inc. (US)

AbbVie Reports Second-Quarter 2024 Financial Results

Corporate News July 25, 2024 AbbVie Reports Second-Quarter 2024 Financial Results Open a printable version of this page Email the URL of this page to a friend Reports Second-Quarter Diluted EPS of $0.77 on a GAAP Basis, a Decrease of 32.5...

Zur Pressemeldung auf news.abbvie.com
12.07

AbbVie Inc. (US) AbbVie Inc. (US)

AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Giant Cell Arteritis

Immunology R&D News July 12, 2024 AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Giant Cell Arteritis Open a printable version of this page Email the URL of this page to a friend Submissions are supported by...

Zur Pressemeldung auf news.abbvie.com
10.07

AbbVie Inc. (US) AbbVie Inc. (US)

AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer

Corporate News R&D News July 10, 2024 AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer Open a printable version of this page Email the URL of this page to a...

Zur Pressemeldung auf news.abbvie.com
02.07

AbbVie Inc. (US) AbbVie Inc. (US)

AbbVie to Host Second-Quarter 2024 Earnings Conference Call

Corporate News July 02, 2024 AbbVie to Host Second-Quarter 2024 Earnings Conference Call Open a printable version of this page Email the URL of this page to a friend NORTH CHICAGO, Ill. , July 2, 2024 / PRNewswire / -- AbbVie (NYSE: ABBV)...

Zur Pressemeldung auf news.abbvie.com
01.07

AbbVie Inc. (US) AbbVie Inc. (US)

Robert A. Michael Assumes Role as AbbVie Chief Executive Officer

Corporate News July 01, 2024 Robert A. Michael Assumes Role as AbbVie Chief Executive Officer Open a printable version of this page Email the URL of this page to a friend As Previously Announced, Richard A. Gonzalez Retires as Chief Executive...

Zur Pressemeldung auf news.abbvie.com
28.06

AbbVie Inc. (US) AbbVie Inc. (US)

AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma

Oncology R&D News June 28, 2024 AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma Open a printable version of this page Email the URL of this page to a...

Zur Pressemeldung auf news.abbvie.com
27.06

AbbVie Inc. (US) AbbVie Inc. (US)

AbbVie Acquires Celsius Therapeutics

Immunology R&D News June 27, 2024 AbbVie Acquires Celsius Therapeutics Open a printable version of this page Email the URL of this page to a friend Celsius' CEL383 is a potential first-in-class anti-Triggering Receptor Expressed on Myeloid...

Zur Pressemeldung auf news.abbvie.com
27.06

AbbVie Inc. (US) AbbVie Inc. (US)

Introducing Allē Payment Plans, Powered by Cherry

Allergan Aesthetics June 27, 2024 Introducing Allē Payment Plans, Powered by Cherry Open a printable version of this page Email the URL of this page to a friend Allē Members Enjoy the Aesthetic Treatments They Love Today, and Pay Over-Time with...

Zur Pressemeldung auf news.abbvie.com
26.06

AbbVie Inc. (US) AbbVie Inc. (US)

U.S. Food and Drug Administration Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Patients with Relapsed or Refractory Follicular Lymphoma

Oncology R&D News June 26, 2024 U.S. Food and Drug Administration Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Patients with Relapsed or Refractory Follicular Lymphoma Open a printable version of this page Email the URL of...

Zur Pressemeldung auf news.abbvie.com

Wem folgen?

Verbund
Folgen
ServusTV
Folgen
Canon
Folgen

Mehr anzeigen

Trends

Black Friday
Folgen
Menschenrechte
Folgen
Advent
Folgen
Aktionstag
Folgen
Gleichstellung
Folgen
Gütesiegel
Folgen
Fachkräftemangel
Folgen

Mehr anzeigen

uncovr pure news - Die neue Art Presseinhalte zu recherchieren. Mehr Info